Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Oct;278(19):3539-49.
doi: 10.1111/j.1742-4658.2011.08256.x. Epub 2011 Aug 24.

TDP-43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration

Affiliations
Review

TDP-43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration

Robert H Baloh. FEBS J. 2011 Oct.

Abstract

Accumulations of aggregated proteins are a key feature of the pathology of all of the major neurodegenerative diseases. Amyotrophic lateral sclerosis (ALS) was brought into this fold quite recently with the discovery of TDP-43 (TAR DNA binding protein, 43 kDa) inclusions in nearly all ALS cases. In part this discovery was fueled by the recognition of the clinical overlap between ALS and frontotemporal lobar degeneration, where ubiquitinated TDP-43 inclusions were first identified. Later the identification of TDP-43 mutations in rare familial forms of ALS confirmed that altered TDP-43 function can be a primary cause of the disease. However, the simple concept that TDP-43 is an aggregation-prone protein that forms toxic inclusions capable of promoting neurodegeneration has not been upheld by initial investigations. This review discusses observations from human pathology, cell culture and animal model systems, to highlight our somewhat murky understanding of the relationship between TDP-43 aggregation and neurodegeneration.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Pathology, biochemistry and domain structure of TDP-43
A) Photomicrograph of TDP-43 immunostaining of a spinal motor neuron in a case of ALS. Courtesy of Dr. Nigel Cairns. B) Schematic diagram of TDP-43 pathology in neurodegeneration. Normally, TDP-43 is present as full length protein in the nucleus. In neurodegenerative diseases, inclusions (commonly skein-like as in A) appear predominantly in the cytosol, with loss of nuclear staining. C) Schematic western blot of detergent insoluble material showing full length and C-terminal fragments of TDP-43, with abnormal phosphorylation. D) Line diagram of TDP-43 showing the RNA binding motifs (RRM1 and RRM2), nuclear localization signal (NLS), nuclear export signal (NES), and location of the ALS/FTLD associated mutations (arrowheads) in the C-terminal domain. The putative location of the prion related domain is shown (see text for details).

References

    1. Skovronsky DM, Lee VM, Trojanowski JQ. Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu Rev Pathol. 2006;1:151–70. - PubMed
    1. Winklhofer KF, Tatzelt J, Haass C. The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases. Embo J. 2008;27:336–49. - PMC - PubMed
    1. Lomen-Hoerth C. Characterization of amyotrophic lateral sclerosis and frontotemporal dementia. Dement Geriatr Cogn Disord. 2004;17:337–41. - PubMed
    1. Leigh PN, et al. Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. Brain. 1991;114 (Pt 2):775–88. - PubMed
    1. Neumann M, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130–3. - PubMed

Publication types

MeSH terms